Live from the NIH registry
Studies recruiting near Macon right now
Top 25 of 73 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1053 — Macon, Georgia (4.5 mi)
· Sponsor: Immunovant Sciences GmbH
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Polycythemia Vera
Phase 3
Interventional 250 participants sought
Central Georgia Cancer Care — Macon, Georgia (4.5 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Gastroenterolgy Associates of Central GA — Macon, Georgia (4.5 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (4.5 mi)
· Sponsor: vTv Therapeutics
Single Versus Dual Implant Fixation of Distal Femur Fractures
Articular Fractures
N/A
Interventional 144 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Wake Forest University Health Sciences
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Central Georgia Cancer Care — Macon, Georgia (4.5 mi)
· Sponsor: Summit Therapeutics
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Lung Cancer Screening, Lung Neoplasms
N/A
Interventional 80 participants sought
Pavilion Family Medicine Center — Warner Robins, Georgia (13.8 mi)
· Sponsor: University of California, Irvine
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Narcolepsy Type 2
Phase 3
Interventional 176 participants sought
Alkermes Investigational Site — Macon, Georgia (4.5 mi)
· Sponsor: Alkermes, Inc.
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Skin Care Physicians of Georgia - Macon- Site Number : 8400030 — Macon, Georgia (4.5 mi)
· Sponsor: Sanofi
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alcohol Use Disorder
Alcohol Use Disorder (AUD)
N/A
Interventional 30 participants sought
Rescue Mission of Middle Georgia — Macon, Georgia (4.5 mi)
· Sponsor: University of Georgia
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (4.5 mi)
· Sponsor: Boehringer Ingelheim
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
EDS, Cataplexy
Phase 3
Interventional 258 participants sought
Sleep Practitioners, LLC — Macon, Georgia (4.5 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Influenza
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research at Primary Pediatrics Macon — Macon, Georgia (4.5 mi)
· Sponsor: Hoffmann-La Roche
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (4.5 mi)
· Sponsor: Hoffmann-La Roche
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
Phase 3
Interventional 1,018 participants sought
Research Site — Macon, Georgia (4.5 mi)
· Sponsor: AstraZeneca
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (4.5 mi)
· Sponsor: Amgen
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
Cutaneous Lichen Planus
Phase 2
Interventional 259 participants sought
Skin Care Physicians Of Georgia — Macon, Georgia (4.5 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Central Georgia Cancer Care - Macon — Macon, Georgia (4.5 mi)
· Sponsor: Mirati Therapeutics Inc.
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Phase 2, Phase 3
Interventional 570 participants sought
Mercer university, Department of internal medicine-Clinical Research ( Site 1512) — Macon, Georgia (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma
Phase 3
Interventional 205 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Children's Oncology Group
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Macon, Georgia (4.5 mi)
· Sponsor: Alnylam Pharmaceuticals
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Atrium Health Navicent — Macon, Georgia (4.5 mi)
· Sponsor: Wake Forest University Health Sciences
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Overweight, Obesity
Phase 3
Interventional 1,035 participants sought
The Jones Center Clinical Research — Macon, Georgia (4.5 mi)
· Sponsor: Eli Lilly and Company